Schedule 13G ownership disclosure

DIFFUSION PHARMACEUTICALS IN

Security class unavailable · CUSIP: 253748305

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,667,574
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000025
Form type
SC 13G/A
Filer
CervoMed Inc.
CIK
CIK 1053691
Filed
Jan 09, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub